Advate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Advate can also be used for perioperative (before, during, and after surgery) care and for routine prophylaxis. The technical name of Advate is Antihemophilic factor (recombinant).
Advate is a clotting factor. Clotting factors work by supplying proteins missing in people with hemophilia.
How do I take it?
Prescribing information states that Advate is given as an intravenous injection.
Advate comes as a powder that must be reconstituted before injection.
The FDA-approved label for Advate lists common side effects including fever, headache, cold symptoms, joint pain, vomiting, and diarrhea.
Rare but serious side effects listed for Advate include life-threatening hypersensitivity reactions and the development of inhibitors.
For more details about this treatment, visit:
Treatment of Hemophilia – Hemophilia Federation of America